Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Athersys stock

Learn how to easily invest in Athersys stock.

Athersys Inc is a biotechnology business based in the US. Athersys shares (ATHX) are listed on the NASDAQ and all prices are listed in US Dollars. Athersys employs 104 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Athersys

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATHX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Athersys stock price (NASDAQ: ATHX)

Use our graph to track the performance of ATHX stocks over time.

Athersys shares at a glance

Information last updated 2022-06-24.
Latest market close$0.27
52-week range$0.18 - $1.81
50-day moving average $0.43
200-day moving average $0.87
Wall St. target price$1.12
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.36

Buy Athersys shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Athersys stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Athersys price performance over time

Historical closes compared with the close of $0.27 from 2022-06-27

1 week (2022-06-22) 2.04%
1 month (2022-05-27) 28.57%
3 months (2022-03-25) N/A
6 months (2021-12-28) -70.56%
1 year (2021-06-29) -80.85%
2 years (2020-06-29) -90.18%
3 years (2019-06-28) 1.68
5 years (2017-06-29) 1.51

Athersys financials

Revenue TTM $8.4 million
Gross profit TTM $-65,566,000
Return on assets TTM -90.23%
Return on equity TTM -424.25%
Profit margin 0%
Book value $0.00
Market capitalisation $65.8 million

TTM: trailing 12 months

Athersys share dividends

We're not expecting Athersys to pay a dividend over the next 12 months.

Have Athersys's shares ever split?

Athersys's shares were split on a 100:167 basis on 4 June 2007. So if you had owned 167 shares the day before before the split, the next day you'd have owned 100 shares. This wouldn't directly have changed the overall worth of your Athersys shares – just the quantity. However, indirectly, the new 67% higher share price could have impacted the market appetite for Athersys shares which in turn could have impacted Athersys's share price.

Athersys share price volatility

Over the last 12 months, Athersys's shares have ranged in value from as little as $0.18 up to $1.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Athersys's is -1.2595. This would suggest that Athersys's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Athersys has bucked the trend.

Athersys overview

Athersys, Inc. , a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K. K.

Frequently asked questions

What percentage of Athersys is owned by insiders or institutions?
Currently 7.503% of Athersys shares are held by insiders and 22.114% by institutions.
How many people work for Athersys?
Latest data suggests 104 work at Athersys.
When does the fiscal year end for Athersys?
Athersys's fiscal year ends in December.
Where is Athersys based?
Athersys's address is: 3201 Carnegie Avenue, Cleveland, OH, United States, 44115-2634
What is Athersys's ISIN number?
Athersys's international securities identification number is: US04744L1061
What is Athersys's CUSIP number?
Athersys's Committee on Uniform Securities Identification Procedures number is: 04744L106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site